Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Self-inactivating retroviral vectors with improved RNA processing.

J Kraunus1, D H S Schaumann, J Meyer

  • 1Department of Cell & Virus Genetics, Heinrich-Pette-Institute, Hamburg, Germany.

Gene Therapy
|September 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemogenetic ON and OFF switches for RNA virus replication.

Nature communications·2021
Same author

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma.

Leukemia·2020
Same author

Treatment of Periprosthetic Femoral Fractures Vancouver Type B2: Revision Arthroplasty Versus Open Reduction and Internal Fixation With Locking Compression Plate.

Geriatric orthopaedic surgery & rehabilitation·2019
Same author

Capsid Engineering Overcomes Barriers Toward Adeno-Associated Virus Vector-Mediated Transduction of Endothelial Cells.

Human gene therapy·2019
Same author

SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.

Gene therapy·2017
Same author

Impact of molecular residual disease post allografting in myelofibrosis patients.

Bone marrow transplantation·2017

New self-inactivating (SIN) retroviral vectors incorporating RNA elements like introns and the woodchuck hepatitis virus post-transcriptional regulatory element (PRE) demonstrate improved transgene expression and splicing, matching or exceeding traditional LTR vectors.

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Retroviral vectors are crucial for gene delivery, but optimizing transgene expression and safety remains a challenge.
  • Key RNA features, including 5'UTR introns, absence of aberrant start codons, and 3'UTR post-transcriptional regulatory elements (PREs), enhance retroviral transgene expression.

Purpose of the Study:

  • To engineer self-inactivating (SIN) retroviral vectors incorporating beneficial RNA elements for improved safety and expression.
  • To evaluate the impact of vector design, specifically promoter insertion site and inclusion of a 5'UTR intron, on vector performance.

Main Methods:

  • Excised the strong retroviral promoter from the 3' LTR and inserted it upstream or downstream of the Psi packaging signal to create SIN vectors.
  • Compared three LTR and four SIN vector designs to assess titer, splice regulation, and transgene expression.

Related Experiment Videos

  • Utilized various cell types including embryonic carcinoma cells, fibroblasts, primary T cells, and hematopoietic progenitor cells.

    • Main Results:

    • SIN vectors exhibited approximately 20-fold lower titers than LTR vectors, but inclusion of the PRE enabled titers exceeding 10^6 infectious units/ml.
    • Intron-containing SIN vectors demonstrated significantly improved splicing compared to state-of-the-art LTR vectors.
    • Transgene expression in SIN vectors matched or surpassed LTR vectors across all tested cell types.

    Conclusions:

    • SIN vectors incorporating specific RNA elements, particularly a 5'UTR intron and PRE, offer a promising strategy for enhanced and safe gene therapy applications.
    • The novel design of SIN vectors with upstream promoter insertion and 5'UTR introns facilitates efficient gene expression and splicing.
    • These optimized SIN vectors represent a significant advancement for retroviral gene delivery systems.